Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0036 Transporter Info
Gene Name	ABCA1
Transporter Name	ATP-binding cassette sub-family A member 1
Gene ID	19
UniProt ID	O95477

Post-Translational Modification of This DT
Overview of ABCA1 Modification Sites with Functional and Structural Information
Sequence	M A C W P Q L R L L L W K N L T F R R R Q T C Q L L L E V A W P L F I F L I L I S V R L S Y P P Y E Q H E C H F P N K A M P S A G T L P W V Q G I I C N A N N P C F R Y P T P G E A P G V V G N F N K S I V A R L F S D A R R L L L Y S Q K D T S M K D M R K V L R T L Q Q I K K S S S N L K L Q D F L V D N E T F S G F L Y H N L S L P K S T V D K M L R A D V I L H K V F L Q G Y Q L H L T S L C N G S K S E E M I Q L G D Q E V S E L C G L P R E K L A A A E R V L R S N M D I L K P I L R T L N S T S P F P S K E L A E A T K T L L H S L G T L A Q E L F S M R S W S D M R Q E V M F L T N V N S S S S S T Q I Y Q A V S R I V C G H P E G G G L K I K S L N W Y E D N N Y K A L F G G N G T E E D A E T F Y D N S T T P Y C N D L M K N L E S S P L S R I I W K A L K P L L V G K I L Y T P D T P A T R Q V M A E V N K T F Q E L A V F H D L E G M W E E L S P K I W T F M E N S Q E M D L V R M L L D S R D N D H F W E Q Q L D G L D W T A Q D I V A F L A K H P E D V Q S S N G S V Y T W R E A F N E T N Q A I R T I S R F M E C V N L N K L E P I A T E V W L I N K S M E L L D E R K F W A G I V F T G I T P G S I E L P H H V K Y K I R M D I D N V E R T N K I K D G Y W D P G P R A D P F E D M R Y V W G G F A Y L Q D V V E Q A I I R V L T G T E K K T G V Y M Q Q M P Y P C Y V D D I F L R V M S R S M P L F M T L A W I Y S V A V I I K G I V Y E K E A R L K E T M R I M G L D N S I L W F S W F I S S L I P L L V S A G L L V V I L K L G N L L P Y S D P S V V F V F L S V F A V V T I L Q C F L I S T L F S R A N L A A A C G G I I Y F T L Y L P Y V L C V A W Q D Y V G F T L K I F A S L L S P V A F G F G C E Y F A L F E E Q G I G V Q W D N L F E S P V E E D G F N L T T S V S M M L F D T F L Y G V M T W Y I E A V F P G Q Y G I P R P W Y F P C T K S Y W F G E E S D E K S H P G S N Q K R I S E I C M E E E P T H L K L G V S I Q N L V K V Y R D G M K V A V D G L A L N F Y E G Q I T S F L G H N G A G K T T T M S I L T G L F P P T S G T A Y I L G K D I R S E M S T I R Q N L G V C P Q H N V L F D M L T V E E H I W F Y A R L K G L S E K H V K A E M E Q M A L D V G L P S S K L K S K T S Q L S G G M Q R K L S V A L A F V G G S K V V I L D E P T A G V D P Y S R R G I W E L L L K Y R Q G R T I I L S T H H M D E A D V L G D R I A I I S H G K L C C V G S S L F L K N Q L G T G Y Y L T L V K K D V E S S L S S C R N S S S T V S Y L K K E D S V S Q S S S D A G L G S D H E S D T L T I D V S A I S N L I R K H V S E A R L V E D I G H E L T Y V L P Y E A A K E G A F V E L F H E I D D R L S D L G I S S Y G I S E T T L E E I F L K V A E E S G V D A E T S D G T L P A R R N R R A F G D K Q S C L R P F T E D D A A D P N D S D I D P E S R E T D L L S G M D G K G S Y Q V K G W K L T Q Q Q F V A L L W K R L L I A R R S R K G F F A Q I V L P A V F V C I A L V F S L I V P P F G K Y P S L E L Q P W M Y N E Q Y T F V S N D A P E D T G T L E L L N A L T K D P G F G T R C M E G N P I P D T P C Q A G E E E W T T A P V P Q T I M D L F Q N G N W T M Q N P S P A C Q C S S D K I K K M L P V C P P G A G G L P P P Q R K Q N T A D I L Q D L T G R N I S D Y L V K T Y V Q I I A K S L K N K I W V N E F R Y G G F S L G V S N T Q A L P P S Q E V N D A I K Q M K K H L K L A K D S S A D R F L N S L G R F M T G L D T K N N V K V W F N N K G W H A I S S F L N V I N N A I L R A N L Q K G E N P S H Y G I T A F N H P L N L T K Q Q L S E V A L M T T S V D V L V S I C V I F A M S F V P A S F V V F L I Q E R V S K A K H L Q F I S G V K P V I Y W L S N F V W D M C N Y V V P A T L V I I I F I C F Q Q K S Y V S S T N L P V L A L L L L L Y G W S I T P L M Y P A S F V F K I P S T A Y V V L T S V N L F I G I N G S V A T F V L E L F T D N K L N N I N D I L K S V F L I F P H F C L G R G L I D M V K N Q A M A D A L E R F G E N R F V S P L S W D L V G R N L F A M A V E G V V F F L I T V L I Q Y R F F I R P R P V N A K L S P L N D E D E D V R R E R Q R I L D G G G Q N D I L E I K E L T K I Y R R K R K P A V D R I C V G I P P G E C F G L L G V N G A G K S S T F K M L T G D T T V T R G D A F L N K N S I L S N I H E V H Q N M G Y C P Q F D A I T E L L T G R E H V E F F A L L R G V P E K E V G K V G E W A I R K L G L V K Y G E K Y A G N Y S G G N K R K L S T A M A L I G G P P V V F L D E P T T G M D P K A R R F L W N C A L S V V K E G R S V V L T S H S M E E C E A L C T R M A I M V N G R F R C L G S V Q H L K N R F G D G Y T I V V R I A G S N P D L K P V Q D F F G L A F P G S V L K E K H R N M L Q Y Q L P S S L S S L A R I F S I L S Q S K K R L H I E D Y S V S Q T T L D Q V F V N F A K D Q S D D D H L K D L S L H K N Q T V V D V A V L T S F L Q D E K V K E S Y V
PTM type	X-Acetylation X-Disulfide bond X-N-glycosylation X-O-glycosylation X-Oxidation X-Palmitoylation X-Phosphorylation X-S-palmitoylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCA1			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	2050
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ABCA1 Lysine 2050 has the potential to affect its expression or activity.
Disulfide bond
Cystine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCA1			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	75
Experimental Method	Co-Immunoprecipitation
Detailed Description	Disulfide bond (-SSR) at ABCA1 Cystine 75 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCA1			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	309
Experimental Method	Co-Immunoprecipitation
Detailed Description	Disulfide bond (-SSR) at ABCA1 Cystine 309 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCA1			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	1463
Experimental Method	Co-Immunoprecipitation
Detailed Description	Disulfide bond (-SSR) at ABCA1 Cystine 1463 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCA1			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	1477
Experimental Method	Co-Immunoprecipitation
Detailed Description	Disulfide bond (-SSR) at ABCA1 Cystine 1477 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	21 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	14
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCA1 Asparagine 14 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCA1			[4]
Role of PTM	Potential impacts
Affected Drug/Substrate	Cholesterol	Results for Drug	Affecting the inward transport of cholesterol
Modified Residue	Asparagine	Modified Location	98
Related Enzyme	N-acetylglucosaminyltransferase V (MGAT5)
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA1 Asparagine 98 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	151
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCA1 Asparagine 151 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	161
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCA1 Asparagine 161 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	196
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCA1 Asparagine 196 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCA1			[5]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	244
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCA1 Asparagine 244 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	292
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCA1 Asparagine 292 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	337
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCA1 Asparagine 337 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	349
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCA1 Asparagine 349 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ABCA1			[4]
Role of PTM	Potential impacts
Affected Drug/Substrate	Cholesterol	Results for Drug	Affecting the inward transport of cholesterol
Modified Residue	Asparagine	Modified Location	400
Related Enzyme	N-acetylglucosaminyltransferase V (MGAT5)
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA1 Asparagine 400 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	478
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCA1 Asparagine 478 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ABCA1			[4]
Role of PTM	Potential impacts
Affected Drug/Substrate	Cholesterol	Results for Drug	Affecting the inward transport of cholesterol
Modified Residue	Asparagine	Modified Location	489
Related Enzyme	N-acetylglucosaminyltransferase V (MGAT5)
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA1 Asparagine 489 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ABCA1			[4]
Role of PTM	Potential impacts
Affected Drug/Substrate	Cholesterol	Results for Drug	Affecting the inward transport of cholesterol
Modified Residue	Asparagine	Modified Location	521
Related Enzyme	N-acetylglucosaminyltransferase V (MGAT5)
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA1 Asparagine 521 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	820
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCA1 Asparagine 820 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1144
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCA1 Asparagine 1144 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1294
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCA1 Asparagine 1294 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence ABCA1			[4]
Role of PTM	Potential impacts
Affected Drug/Substrate	Cholesterol	Results for Drug	Affecting the inward transport of cholesterol
Modified Residue	Asparagine	Modified Location	1453
Related Enzyme	N-acetylglucosaminyltransferase V (MGAT5)
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA1 Asparagine 1453 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence ABCA1			[4]
Role of PTM	Potential impacts
Affected Drug/Substrate	Cholesterol	Results for Drug	Affecting the inward transport of cholesterol
Modified Residue	Asparagine	Modified Location	1504
Related Enzyme	N-acetylglucosaminyltransferase V (MGAT5)
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA1 Asparagine 1504 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence ABCA1			[4]
Role of PTM	Potential impacts
Affected Drug/Substrate	Cholesterol	Results for Drug	Affecting the inward transport of cholesterol
Modified Residue	Asparagine	Modified Location	1637
Related Enzyme	N-acetylglucosaminyltransferase V (MGAT5)
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at ABCA1 Asparagine 1637 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	2044
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCA1 Asparagine 2044 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	2238
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCA1 Asparagine 2238 has the potential to affect its expression or activity.
O-glycosylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCA1			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	350
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at ABCA1 Serine 350 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCA1			[7]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	2124
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at ABCA1 Cystine 2124 has the potential to affect its expression or activity.
Palmitoylation
Cysteine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Increasing ABCA1's hydrophobic property and it-mediated cholesterol efflux			[4] , [8]
Role of PTM	Properties Modulation
Affected Drug/Substrate	Cholesterol	Results for Drug	Incerasing efflux of cholesterol
Modified Residue	Cysteine	Modified Location	1110
Related Enzyme	Palmitoyltransferase ZDHHC8 (ZDHHC8)
Experimental Material(s)	Human embryonic kidney (Flp-In 293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Palmitoylation at ABCA1 Cysteine 1110 have been reported to increasing its hydrophobic property and it mediated cholesterol efflux.
PTM Phenomenon 2	Increasing ABCA1's hydrophobic property and it-mediated cholesterol efflux			[4] , [8]
Role of PTM	Properties Modulation
Affected Drug/Substrate	Cholesterol	Results for Drug	Incerasing efflux of cholesterol
Modified Residue	Cysteine	Modified Location	1111
Related Enzyme	Palmitoyltransferase ZDHHC8 (ZDHHC8)
Experimental Material(s)	Human embryonic kidney (Flp-In 293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Palmitoylation at ABCA1 Cysteine 1111 have been reported to increasing its hydrophobic property and it mediated cholesterol efflux.
PTM Phenomenon 3	Increasing localization of ABCA1 at the plasma membrane and enhancing ability of ABCA1 to efflux lipids to lipoprotein A-I			[8]
Role of PTM	Trafficking to Plasma Membrane
Affected Drug/Substrate	Lipids	Results for Drug	Regulating efflux of lipid
Modified Residue	Cysteine	Modified Location	3
Related Enzyme	Palmitoyltransferase ZDHHC8 (ZDHHC8)
Experimental Material(s)	Human embryonic kidney (Flp-In 293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Palmitoylation at ABCA1 Cysteine 3 have been reported to increase its localization at the plasma membrane and enhance its ability to efflux lipids to lipoprotein A-I.
PTM Phenomenon 4	Increasing localization of ABCA1 at the plasma membrane and enhancing ability of ABCA1 to efflux lipids to lipoprotein A-I			[8]
Role of PTM	Trafficking to Plasma Membrane
Affected Drug/Substrate	Lipids	Results for Drug	Regulating efflux of lipid
Modified Residue	Cysteine	Modified Location	23
Related Enzyme	Palmitoyltransferase ZDHHC8 (ZDHHC8)
Experimental Material(s)	Human embryonic kidney (Flp-In 293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Palmitoylation at ABCA1 Cysteine 23 have been reported to increase its localization at the plasma membrane and enhance its ability to efflux lipids to lipoprotein A-I.
Phosphorylation
Serine	29 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Enhancing the activity of ABCA1			[9]
Role of PTM	Protein Activity Modulation
Affected Drug/Substrate	Phospholipid	Results for Drug	Regulating efflux of phospholipid
Modified Residue	Serine	Modified Location	2054
Related Enzyme	cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 2054 have been reported to enhance its transport activity.
PTM Phenomenon 2	No significant impaired transporter			[9]
Role of PTM	No Significant Effect
Modified Residue	Serine	Modified Location	1042
Related Enzyme	cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1042 have been reported to have no significant effect on its expression or subcellular localisation, nor did it affect the rate of drug transport.
PTM Phenomenon 3	Have the potential to influence ABCA1			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	116
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 116 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCA1			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	121
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 121 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	231
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 231 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCA1			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	870
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 870 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCA1			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	884
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 884 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1031
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1031 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ABCA1			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1137
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1137 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ABCA1			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1138
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1138 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ABCA1			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1140
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1140 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ABCA1			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1141
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1141 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ABCA1			[12] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1145
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1145 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ABCA1			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1146
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1146 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ABCA1			[12] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1147
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1147 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence ABCA1			[17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1159
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1159 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence ABCA1			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1255
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1255 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence ABCA1			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1262
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1262 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence ABCA1			[13] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1280
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1280 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence ABCA1			[14] , [20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1296
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1296 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence ABCA1			[20] , [21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1302
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1302 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence ABCA1			[20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1309
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1309 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence ABCA1			[22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1536
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1536 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence ABCA1			[23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1540
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1540 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1548
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1548 has the potential to affect its expression or activity.
PTM Phenomenon 26	Have the potential to influence ABCA1			[24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1953
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1953 has the potential to affect its expression or activity.
PTM Phenomenon 27	Have the potential to influence ABCA1			[24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1954
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 1954 has the potential to affect its expression or activity.
PTM Phenomenon 28	Have the potential to influence ABCA1			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	2101
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 2101 has the potential to affect its expression or activity.
PTM Phenomenon 29	Have the potential to influence ABCA1			[14] , [25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	2234
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Serine 2234 has the potential to affect its expression or activity.
Threonine	14 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCA1			[10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	120
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Threonine 120 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCA1			[26]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	246
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Threonine 246 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCA1			[27]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	386
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Threonine 386 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCA1			[27]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	389
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Threonine 389 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCA1			[27]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	392
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Threonine 392 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCA1			[12] , [16]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1148
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Threonine 1148 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCA1			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1242
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Threonine 1242 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ABCA1			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1243
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Threonine 1243 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ABCA1			[26]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1261
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Threonine 1261 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ABCA1			[28]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1286
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Threonine 1286 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ABCA1			[20] , [21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1305
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Threonine 1305 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ABCA1			[29]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1582
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Threonine 1582 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ABCA1			[30]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1586
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Threonine 1586 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ABCA1			[16]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	2240
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Threonine 2240 has the potential to affect its expression or activity.
Tyrosine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCA1			[10]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	115
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Tyrosine 115 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCA1			[31]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	325
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Tyrosine 325 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCA1			[32] , [33]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1206
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Tyrosine 1206 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCA1			[34] , [35]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1513
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCA1 Tyrosine 1513 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCA1			[36]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	3
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation (-S-Palm) at ABCA1 Cystine 3 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCA1			[36]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	23
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation (-S-Palm) at ABCA1 Cystine 23 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCA1			[36]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	1110
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation (-S-Palm) at ABCA1 Cystine 1110 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCA1			[36]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	1111
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation (-S-Palm) at ABCA1 Cystine 1111 has the potential to affect its expression or activity.
Ubiquitination
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Significantly decreased the protein levels			[4]
Role of PTM	Surface Expression Modulation
Affected Drug/Substrate	Cholesterol	Results for Drug	Affecting the inward transport of cholesterol
Modified Residue	Lysine
Related Enzyme	E3 ubiquitin-protein ligase HECTD1 (HECTD1)
Studied Phenotype	Leukemia [ICD11: 2A20-2B3Z]
Experimental Material(s)	Human leukemia monocytic (THP-1) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCA1 Lysine have been reported to significantly decrease its protein levels.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Decreasing the degradation of the cell surface-resident ABCA1			[37]
Role of PTM	Degradation via Lysosome
Studied Phenotype	Liver cancer [ICD11: 2C12]
Experimental Material(s)	Human hepatoma (HuH-7) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCA1 have been reported to decrease degradation of the cell surface-resident transporter.

References
1	Synthesis of small polymeric nanoparticles sized below 10 nm via polymerization of a cross-linker in a glassy polymer matrix. Chem Commun (Camb). 2009 Nov 7;(41):6234-6.
2	iCysMod: an integrative database for protein cysteine modifications in eukaryotes. Brief Bioinform. 2021 Sep 2;22(5):bbaa400. (ID: O95477)
3	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: ABCA1_HUMAN)
4	Role of ABCA1 in Cardiovascular Disease. J Pers Med. 2022 Jun 20;12(6):1010.
5	Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61.
6	Mapping and Quantification of Over 2000 O-linked Glycopeptides in Activated Human T Cells with Isotope-Targeted Glycoproteomics (Isotag). Mol Cell Proteomics. 2018 Apr;17(4):764-775.
7	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
8	Palmitoylation of ATP-binding cassette transporter A1 is essential for its trafficking and function. Circ Res. 2009 Jul 17;105(2):138-47.
9	Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux. J Biol Chem. 2002 Nov 1;277(44):41835-42.
10	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
11	Quantitative phosphoproteomic analysis of acquired cancer drug resistance to pazopanib and dasatinib. J Proteomics. 2018 Jan 6;170:130-140.
12	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
13	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
14	Determination of Site-Specific Phosphorylation Ratios in Proteins with Targeted Mass Spectrometry. J Proteome Res. 2018 Apr 6;17(4):1654-1663.
15	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
16	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
17	An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.
18	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
19	Phosphorylation by protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporter. J Biol Chem. 2004 Sep 3;279(36):37779-88.
20	CEP128 Localizes to the Subdistal Appendages of the Mother Centriole and Regulates TGF-beta/BMP Signaling at the Primary Cilium. Cell Rep. 2018 Mar 6;22(10):2584-2592.
21	Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling. J Proteome Res. 2017 Mar 3;16(3):1121-1132.
22	Retinal ganglion cell layer thickness and local visual field sensitivity in glaucoma. Arch Ophthalmol. 2011 Dec;129(12):1529-36.
23	Risk assessment models for late age-related macular degeneration. Arch Ophthalmol. 2011 Dec;129(12):1605-6.
24	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
25	Bone fragility in diabetes: novel concepts and clinical implications. Lancet Diabetes Endocrinol. 2022 Mar;10(3):207-220.
26	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
27	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
28	Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J Biol Chem. 2003 Sep 26;278(39):37368-74.
29	Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, S rc- r elated Kinase Lacking C-terminal Regulatory Tyrosine and N-terminal M yristoylation S ites (SRMS). Mol Cell Proteomics. 2018 May;17(5):925-947.
30	Motif-specific sampling of phosphoproteomes. J Proteome Res. 2008 May;7(5):2140-50.
31	Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. Cancer Res. 2012 May 15;72(10):2501-11.
32	Insulin down-regulates specific activity of ATP-binding cassette transporter A1 for high density lipoprotein biogenesis through its specific phosphorylation. Atherosclerosis. 2011 Jun;216(2):334-41.
33	Effect of cadmium on the microsomal liver enzymes of the rat. Arch Exp Veterinarmed. 1980;34(3):417-24.
34	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
35	Identification of Candidate Cyclin-dependent kinase 1 (Cdk1) Substrates in Mitosis by Quantitative Phosphoproteomics. Mol Cell Proteomics. 2016 Jul;15(7):2448-61.
36	In Silico Identification of Protein S-Palmitoylation Sites and Their Involvement in Human Inherited Disease. J Chem Inf Model. 2015 Sep 28;55(9):2015-25.
37	Ubiquitination is associated with lysosomal degradation of cell surface-resident ATP-binding cassette transporter A1 (ABCA1) through the endosomal sorting complex required for transport (ESCRT) pathway. Hepatology. 2011 Aug;54(2):631-43.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence